Clinical disability progression and platelet GP IIb/IIIa values in patients with atopic myelitis

J Neuroimmunol. 2012 May 15;246(1-2):108-12. doi: 10.1016/j.jneuroim.2012.03.009. Epub 2012 Apr 5.

Abstract

We aimed to clarify the disability progression and platelet aggregative function in atopic myelitis (AM). Seventeen AM patients and 35 healthy controls were subjected to clinico-allergological evaluations and glycoprotein IIb/IIIa (GP IIb/IIIa) measurements using a VerifyNow assay system. In AM patients, the disease duration had significant positive correlations with the Kurtzke Expanded Disability Status Scale scores and Sensory Functional Scale scores. The GP IIb/IIIa values were significantly higher in AM patients than in controls as well as in females compared with males. AM is essentially a progressive disease affecting the sensory system, and involves an increased platelet aggregative function.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Disability Evaluation*
  • Disease Progression*
  • Female
  • Humans
  • Hypersensitivity, Immediate / immunology
  • Hypersensitivity, Immediate / metabolism
  • Hypersensitivity, Immediate / physiopathology
  • Male
  • Myelitis / immunology*
  • Myelitis / metabolism*
  • Myelitis / physiopathology
  • Platelet Aggregation / immunology
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism*
  • Sensation / immunology
  • Up-Regulation / immunology

Substances

  • Platelet Glycoprotein GPIIb-IIIa Complex